Successful treatment of hepatitis C virus infection combining daclatasvir and simeprevir in a heart transplant recipient with decompensated cirrhosis

J Heart Lung Transplant. 2016 Jul;35(7):949-51. doi: 10.1016/j.healun.2016.05.005. Epub 2016 May 17.

Authors

Teresa Casanovas¹, Josep Roca², Jordi Niubó³

Affiliations

¹ Liver Transplant Unit; Gastroenterology Service.
² Cardiology Service.
³ Microbiology Service, Hospital Universitari de Bellvitge, Barcelona, Spain.

PMID: 27311374
DOI: 10.1016/j.healun.2016.05.005

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antiviral Agents / therapeutic use
Carbamates
Drug Therapy, Combination
Heart Transplantation*
Hepatitis C / complications
Hepatitis C / drug therapy*
Hepatitis C / virology
Humans
Imidazoles / therapeutic use*
Liver Cirrhosis / diagnosis
Liver Cirrhosis / drug therapy*
Liver Cirrhosis / etiology
Male
Middle Aged
Pyrrolidines
Simeprevir / therapeutic use*
Valine / analogs & derivatives

Substances

Antiviral Agents
Carbamates
Imidazoles
Pyrrolidines
Simeprevir
Valine
daclatasvir